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Background: To estimate the proportion and  peak age 
of rotavirus diarrhoea among children of age two months 
to five years   
Methods: In this descriptive study five hundred 
patients with acute watery diarrhoea (AWD)  were 
screened for rotavirus. Stool sample of about 5 ml was 
taken & tested in the laboratory for group A rotavirus 
antigen by Enzyme immunoassays (EIA).  
Results: Mean age of  patients  with AWD was 12.5 
months . Out of 500 patients  147  ( 29.4%)  were positive 
for group A rotavirus. Majority of positive patients 116/147 
(78.9%)  were in the  age group 2 months to 12 months. 
Conclusions: As there are many types of rotavirus i.e. 
A, B, C, D, and E so overall burden for all serotypes will be 
much higher.  Rotavirus vaccine is an effective preventive 
measure available against rotavirus diarrhea.  
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Introduction 
 
Rotaviruses are most common cause of acute 
watery diarrhea in children worldwide. It is estimated 
that Rotavirus causes 125-million diarrheal cases/year. 
Rotavirus diarrhea deaths account for 20-40 
deaths/year in developed countries and  440,000 
deaths/year in developing countries. About 1/3 of 
these deaths occur in Indian subcontinent.1 
 Rotavirus diarrhea is more common during 
winter season in temperate climate. Peak age of 
Rotavirus diarrhea in children is 3 months to 2 years.2 
Rotavirus infection is transmitted through feco-oral 
route. After incubation period of 48 hours, patient 
develops fever and vomiting followed by profuse 
watery diarrhea lasting for 5 to 7 days.2 
 Many studies are being done worldwide to 
estimate the incidence and prevalent strains of 
rotavirus gastroenteritis which will help in decision 
making for implementation of immunization against 
rotavirus. In India, there is marked diversity of 
rotavirus strains reported by studies performed in 18 
Indian cities. Rotaviruses were detected in 23.4% of 
patients presenting to hospital with diarrhea.3 In 
Australia, most prevalent serotype is G1 strain.4 
A study conducted in America from 2002 to 
2005, has shown diversity of group A rotavirus strains, 
most common G genotype detected was G9. Changes 
in the G genotype frequency were observed from year 
to year.5   
 It is estimated that in Asia 171,000 children 
will die of rotavirus diarrhea, 1.9 million will be 
hospitalized and 13.5 million will require outpatient 
visit by the time Asian cohort reaches 5 years of age 
and medical cost will approximate 
$191million.Rotavirus vaccine could be cost-effective 
and valuable in preventing rotavirus diarrhea 
associated morbidity and mortality.6  China is 2nd 
highest in mortality due to rotavirus and the only 
country licensed for rotavirus vaccination.7 
 Clinically rotavirus diarrhea mimics any other 
cause of acute watery diarrhea and is treated with 
standard management protocol, i.e., oral rehydration 
therapy and continued feeding. Anti- infective agent - 
nitazoxanide has reduced the duration of severe 
Rotavirus diarrhea in a study of hospitalized children 
in Egypt. 8  Use of probiotics for treatment of Rotavirus 
diarrhea has shown improvement in mild cases but no 
role in dehydrating disease.9      Hence the only cost-
effective option is prevention of rotavirus diarrhea 
through rotavirus vaccination. 10 Currently two new 
live, oral, attenuated pentavalent and monovalent 
vaccines against rotavirus diarrhea have been licensed 
by the European Medicines Agency and the US Food 
and Drug Administration, respectively, in 2006.11 
Pentavalent Human-Bovine reassortant rotavirus 
vaccine (HBRV) directed against rotavirus is being 
tried. HBRV vaccine has shown 68.8%-76.6%efficacy 
against any rotavirus diarrhea and 100% efficacy 
against severe rotavirus diarrhea.12 The pentavalent 
vaccine protects against rota virus diarrhea when 
administered as 3 dose series at 2,4, and 6 months of 
age. The 1st dose should be administered between 6 
and 12 weeks of age, with all three doses completed by 
32 wk of age. Clinical trials in Europe, Latin America, 
and the US have demonstrated that these vaccines are 
safe and highly efficacious for preventing rotavirus-
associated severe gastroenteritis.13 
   In Pakistan, very little research is conducted 
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 regarding frequency of rotavirus diarrhea. This study 
was done  to estimate burden and peak age of 
rotavirus diarrhea, so as to justify the recommendation 
and use of rotavirus vaccination at particular age as a 
preventive measure/tool.  
 
Patients and Methods 
 
It was a descriptive case series study 
conducted in the Department of Paediatrics, 
Rawalpindi General Hospital in 1 year duration from 
6th November 2006 to 5 th November 2007. 
 Admitted patients of age two months to five 
years with non-bloody acute watery diarrhea were 
screened for rotavirus. Stool sample of about 5 ml was 
taken in screw top container within 48 hours of 
admission and kept in refrigerator before being tested 
in the hospital laboratory for rotavirus antigen by 
Enzyme immunoassays (EIA).EIA test was performed 
by centrifuging the stool sample with reagent (DAKO 
IDEIA rotavirus EIA detection kit) at 20-30 C for 20 
min.  
Results were interpreted by 2 methods - visual 
and photometric determination and by comparing 
them with standard positive and negative controls. 
Limitations of test were that it detected only group A 
rotaviruses & test could be false negative in case of 
improper sampling e.g. stool sample taken after 3-5 
days or not refrigerated. 
 In order to determine the peak age 
prevalence of rotavirus diarrhea, patients were 
divided into age groups i-e ,Group 1 =2months – 12 
months ;   Group 2 =13months – 24 months ;Group 3 
=25months –36 months  ; Group 4 =37months-
48months;Group 5 = 49months – 60months 
 Data was analyzed using SPSS version 
10.Mean +S.D was estimated for quantitative variable 
i.e age. Simple Frequency tables were used for 
qualitative variables. Proportion was calculated for 
disease burden and peak age was measured using 
mode in frequency distribution of age.  
 
Results 
 
Of the 500 pts with AWD of age 2months-
60months enrolled in study , 260  (52%) were male and 
240 (48%) were female. Mean age of all pts with AWD 
was 12.5 months with SD of 11.7. Out of 500 patients 
screened for rotavirus 147 pts ( 29.4%)  were positive 
for group A rotavirus and 355 pts( 70.6 % ) were 
negative (Fig.1), Out of 147 patients (29.4%) positive 
for Rota virus 116 pts (78.9%) fell into age Group 1 (2m 
to12m) so peak age  was found to be 2months -
12months(Table.1). Mean age of rotavirus positive pts 
was 10.4 months with SD of 7.8. 
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Fig 1: Rota virus positive cases in stool 
 
Table 1: Rota virus AWD:  case distribution 
according to age  
Age groups Frequency Percentage 
Group 1 
(2 to 12 months) 116 78.9 
Group 2 
13-24months 23 15.6 
Group 3 
25-36months 6 4.1 
Group 4 
37-48months 2 1.4 
Group 5 
49-60months 0 0 
Total 147 100 
 
Discussion 
 
In Asia 171,000 children die of rotavirus. 
China is 2nd highest in mortality due to rotavirus. In 
Bangladesh between 5,756 and 13,430 children died 
each year in between 2001 and 2004 from severe 
rotavirus gastroenteritis.14 In Pakistan very little 
research is being conducted regarding prevalence of 
rotavirus diarrhea. Preventive measures like good 
hygienic measures and improved sanitation have no 
specific role in prevention, so vaccination is the only 
preventive tool.  
 In present study burden of only Group A 
rotavirus estimated was 29.4%. Similar studies from 
different countries have shown different results. In 
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Indonesia rotavirus prevalence was about 45.5%.15  In 
India Rotavirus positivity rates of Group A rotavirus 
in hospitalized patients were 20%. 16 In another study 
from Italy, Rotavirus was observed in 29.5% of 
children with AWD17 & in France general prevalence 
of Rotavirus diarrhea was 27.9%. 17 
In present study peak age of rotavirus 
diarrhea was 2 months to 12 months. A study 
conducted in Isfahan, Iran has shown that 84.2% of 
cases with rotavirus gastroenteritis were less than 2 
years of age with peak age between 6-12 months.18 In 
another study conducted in Yangon, Myanmar  
showed Rotavirus diarrhea most frequently occurred 
in children 6-17 months of age, and it was more 
commonly identified in boys (62%)19 ,whereas in 
present study rotavirus was more commonly 
identified in girls(52%).A study from Denmark has 
shown that rotavirus diarrhea admissions peaked 
twice during early childhood i-e between 7-12 months 
of age and 79% of admissions had occurred before the 
age of 2 years ; proportion by sex were 56% boys and 
44% girls.20 I  In conclusion further studies are needed 
to find out overall burden of disease from all serotypes 
of rotavirus. As vaccination is the only cost-effective 
preventive strategy for rotavirus diarrhea so  the role 
of vaccination  against Rota virus must be highlighted 
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